Hyphens Pharma reports higher earnings for FY2024 of $10.9 mil after acquisition of Ardence Pharma

Pharmaceutical company, Hyphens Pharma, has reported earnings of $10.9 million for its FY2024 ended Dec 31, 2024, a 26.5% y-o-y increase. 

However for the 2HFY2024 reporting period, the group reported a 1.5% y-o-y decrease in earnings of $4.98 million.